Related Experiment Video

Updated: Jul 19, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference

H Sumimoto1, S Yamagata, A Shimizu

  • 1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.

Gene Therapy
|September 24, 2004
PubMed

Insights

RNA interference targeting Skp-2 effectively inhibited cancer cell growth by increasing cell cycle regulators. This Skp-2 RNAi strategy shows promise for gene therapy in cancers with high Skp-2 expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Therapy

Background:

  • Skp-2 overexpression disrupts cell cycle regulation by degrading key proteins like p27Kip1, p21, and c-myc.
  • This dysregulation is a common mechanism in various cancers, making Skp-2 a potential therapeutic target.

Purpose of the Study:

  • To evaluate the efficacy of RNA interference (RNAi) targeting Skp-2 as a cancer gene therapy strategy.
  • To assess the impact of Skp-2 inhibition on cancer cell growth and tumor development.

Main Methods:

  • Utilized HIV-lentiviral and adenoviral vectors for Skp-2 RNA interference in human small-cell lung carcinoma cells.
  • Administered adenovirus siRNA vectors intratumorally in NOD/SCID mice bearing established subcutaneous tumors.

Main Results:

  • HIV-lentivirus-mediated Skp-2 RNAi efficiently inhibited in vitro cancer cell growth by upregulating p27Kip1 and p21.
  • Adenovirus siRNA vector administration significantly inhibited established tumor growth in vivo.
  • The therapeutic effect was observed in cancer cells with high Skp-2 expression, with no significant impact on cells lacking high Skp-2.

Conclusions:

  • Skp-2 RNA interference is a viable strategy for inhibiting cancer cell proliferation and tumor growth.
  • This approach holds potential for targeted gene therapy in cancers characterized by elevated Skp-2 levels.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...